Published on
August 24, 2020
- 13:00 GMT
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
Primary objectives expand evaluation of immunogenicity and safety Secondary objectives include preliminary efficacy assessment Trial to enroll up to 1,500 volunteers in United States and Australia, with approximately 50 percent between 60 and 84 years of …
Distribution channels:
Media, Advertising & PR, Technology
...
